Track the 뉴로핏 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 뉴로핏 has logged 2 reports. Market capitalisation: €89bn. The latest transaction was filed on 30 April 2026 (Purchase). Among the most active insiders: 김창일. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Neurofit es una empresa que opera en el sector de la salud y farmacéutico, cotizada en el mercado XKRX. Se enfoca en el desarrollo de soluciones innovadoras para mejorar la salud del paciente.